|
No. | RT | Formula | Identification | m/z [M + H]+ | Error (ppm) | MS/MS | Origin |
|
1 | 1.43 | C7H6O3 | 4-Hydroxybenzoic acid isomer | 139.0386 | 2.68 | 121.0281[M + H-H2O]+; 95.04889[M + H-CO2]+ | PF |
2 | 1.45 | C7H12O6 | Quinic acidR | 193.0702 | 2.42 | 147.0650[M + H-CH2O-O]+; 129.0544[M + H-CH2O-O-H2O]+; 111.0439[M + H-CH2O-O-2H2O]+ | EH |
3 | 1.49 | C36H36N2O8 | Lyciumamide B | 625.2541 | 0.55 | 607.2366[M + H-H2O]+; 589.2355CFM_ID | LF |
4 | 1.51 | C7H6O5 | Gallic acid isomer | 171.0283 | 2.94 | 153.0199[M + H-H2O]+; 127.0386[M + H-CO2]+MB | PRR/AJH |
5 | 1.55 | C7H6O3 | 4-Hydroxybenzoic acid | 139.0386 | 2.68 | 121.0281[M + H-H2O]+; 95.0490[M + H-CO2]+ | PF |
6 | 1.75 | C13H18O7 | Isosalicin | 287.1112 | 4.65 | 125.0594[M + H-glu]+ | PRR |
7 | 1.95 | C6H6O2 | 5-Methyl furan aldehyde | 111.0438 | 2.33 | 83.0489[M + H-CO]+ | SCF |
8 | 1.95 | C9H11NO2 | Phenylalanine isomer | 166.0860 | 1.55 | 91.0539MoNA | PF |
9 | 1.97 | C9H8O3 | p-Hydroxy-cinnamic acid | 165.0543 | 1.95 | 121.0635[M + H-CO2]+ MoNA | LF, PF |
10 | 2.22 | C5H7NO3 | Pyroglutamic acidR | 130.0499 | −0.24 | 84.0442 | PF |
11 | 11.23 | C14H16O9 | Bergenin | 329.0880 | −3.94 | 311.0752[M + H-H2O]+; 293.0647[M + H-2H2O]+; 275.0543[M + H-3H2O]+; 263.0543; 233.0439 | AJH |
12 | 11.69 | C16H18O9 | Cis-Cryptochlorogenic acid/trans-Cryptochlorogenic acid/Chlorogenic acid | 355.1045 | −6.05 | 163.0376MB | EH |
13 | 11.82 | C39H50O26 | Quercetin-rha-tri-hex | 935.2681 | −1.92 | 303.0463[M + H-rha-3hex]+ | LF |
14 | 11.96 | C23H28O12 | OxypaeoniflorinR | 497.1668 | −2.92 | 335.1158[M + H-glu]+; 133.0636; 121.0282 | PR |
15 | 12.00 | C17H26O10 | LoganinR | 391.1616 | −4.43 | 229.1065[M + H-glu]+; 197.0808; 179.0699 | PF, AJH/AJH |
16 | 16.15 | C27H30O14 | Apigenin-rha-glu | 579.1729 | −3.58 | 433.1132[M + H-rha]+; 271.0596[M + H-rha-glu]+ | FTB, EH |
17 | 16.21 | C32H38O16 | Hexandraside E | 679.2266 | −4.92 | 517.1617[M + H-glu]+; 355.1173[M + H-2glu]+; 299.0549[M + H-2glu-isobutenyl]+ | EH |
18 | 16.23 | C21H20O11 | Kaempferol-3-O-gal | 449.1095 | −3.71 | 287.0539[M + H-glu]+; 263.0550; 245.0442 | AJH, EH/FTB, EH |
19 | 16.35 | C23H28O11 | Albiflorin | 481.1723 | −3.88 | 319.1169[M + H-glu]+ | PR |
20 | 16.55 | C27H30O14 | RhoifolinR | 579.1729 | −3.58 | 433.1132[M + H-rha]+; 271.0596[M + H-rha-glu]+ | EH |
21 | 16.72 | C22H22O10 | Calycosin-7-O-glu or its isomer (a) | 447.1287 | −0.28 | 285.0749[M + H-glu]+ | AR |
22 | 16.79 | C28H34O15 | HesperidinR | 611.1998 | −4.51 | 465.1387[M + H-rha]+; 303.0860[M + H-rha-glu]+; 177.0545; 153.0181; 85.0283 | CRP |
23 | 16.81 | C18H16O7 | Dihydroxy-trimethoxyflavone | 345.0985 | −4.71 | 287.0555[M + H-2CH3-CO]+; 153.0179 | CRP |
24 | 16.81 | C22H24O11 | Hesperetin-7-O-glu or its isomer (a) | 465.1396 | −1.00 | 303.086[M + H-glu]+ | GRR |
25 | 16.89 | C21H22O10 | Prunin | 435.1294 | −1.90 | 417.0648[M + H-H2O]+; 343.1283; 273.0755[M + H-glu]+ | CRP |
26 | 16.93 | C18H16O8 | Rosmarinic acidR | 361.0907 | 3.04 | 163.0384; 145.0273; 135.0429 | PF/CRP |
27 | 16.97 | C33H53NO8 | Sibelicin glycoside | 592.3843 | 0.16 | 574.3731[M + H-H2O]+; 430.3316[M + H-glu]+; 412.3208[M + H-glu-H2O]+ | FTB |
28 | 17.09 | C22H22O11 | Diosmetin-6-C-glu/Pratensein-7-O-glu (a) | 463.1247 | −2.62 | 301.0703[M + H-glu]+ | CRP/AR |
29 | 17.15 | C21H20O10 | Apigenin-8-C-glu | 433.1146 | −3.88 | 271.0602[M + H-glu]+ | CRP |
30 | 17.19 | C28H32O15 | DiosminR | 609.1825 | −1.81 | 463.1224[M + H-rha]+;301.0696[M + H-rha-glu]+;286.0461[M + H-rha-glu-CH3]+ | CRP |
31 | 17.31 | C27H41NO3 | Peimisine isomer (a) | 428.3171 | −2.76 | 410.3067[M + H-H2O]+ | FTB |
32 | 17.43 | C17H14O8 | Tetrahydroxy-dimethoxyflavone (a) | 347.0753 | 2.44 | 287.0543[M + H-2OCH3]+ | CRP |
33 | 17.47 | C21H18O11 | Apigenin-7-O-gluA | 447.0931 | −2.04 | 271.0589[M + H-gluA]+; 167.0556 | PF |
34 | 17.72 | C27H41NO3 | PeimisineR | 428.3171 | −2.76 | 410.3026[M + H-H2O]+ | FTB |
35 | 17.86 | C32H38O15 | Des-O-methylicariin/epimedoside A | 663.2299 | −2.35 | 517.1711[M + H-rha]+; 355.1168[M + H-rha-glu]+; 299.0544[M + H-rha-glu-isobutenyl]+ | EH |
36 | 17.94 | C22H22O11 | Diosmetin-6-C-glu/pratensein-7-O-glu (b) | 463.1242 | 1.54 | 301.0701[M + H-glu]+ | CRP/AR |
37 | 18.00 | C15H16O4 | Meranzin/isomeramazin (a) | 261.1117 | 1.67 | 189.0547; 131.0487MB | CRP |
38 | 18.30 | C16H14O6 | Hesperetin | 303.0875 | −3.92 | 177.0547; 171.0288; 153.0182 [24] | CRP |
39 | 18.30 | C22H24O11 | Hesperetin-7-O-glu or its isomer (b) | 465.1396 | −1.00 | 303.0856[M + H-glu]+ | GRR |
40 | 18.52 | C27H41NO3 | Peimisine isomer (b) | 428.3171 | −2.76 | 410.3055[M + H-H2O]+ | FTB |
41 | 19.03 | C33H55O8N | Zhebeininoside | 594.4004 | −0.60 | 576.3881[M + H-H2O]+; 414.3357[M + H-H2O-glu]+ | FTB |
42 | 19.17 | C27H45NO3 | Peimine AR | 432.3473 | −0.81 | 414.3361[M + H-H2O]+; 398.3082 | FTB |
43 | 19.91 | C27H41NO3 | Peimisine isomer (c) | 428.3171 | −2.76 | 410.2988[M + H-H2O]+; 337.2122 | FTB |
44 | 20.15 | C27H41O4N | Peimisine nitrogen oxide | 444.3102 | 1.43 | 398.3026[M + H-CH2O-O]+; 98.0961 | FTB |
45 | 20.23 | C27H41NO3 | Peimisine isomer (d) | 428.3171 | −2.76 | 410.2950[M + H-H2O]+ | FTB |
46 | 21.17 | C9H10O3 | Ethyl 4-hydroxybenzoate | 167.0700 | 1.63 | 123.0436[M + H-C2H2O]+ | EH |
47 | 21.2 | C23H26O10 | Lactiflorin | 463.1588 | 2.32 | 167.0701; 123.0441 [25] | PR |
48 | 21.26 | C15H12O5 | Naringenin isomer (a) | 273.0750 | 2.76 | 247.0427 [24] | CRP |
49 | 21.32 | C27H43NO3 | Peiminine BR | 430.3306 | 2.26 | 412.3206[M + H-H2O]+; 396.2866 | FTB |
50 | 21.53 | C39H50O20 | Epimedin A (hexandraside F) isomer | 839.2953 | 1.81 | 677.2344[M + H-glu]+; 531.1817[M + H-glu-rha]+; 369.1326[M + H-2glu-rha]+; 313.0698[M + H-2glu-rha-isobutenyl]+ | EH |
51 | 21.78 | C33H53NO7 | Yibeinoside A or its isomer (a) | 576.3880 | 2.57 | 414.3339[M + H-glu]+ | FTB |
52 | 21.80 | C9H10O3 | Paeonol isomer | 167.0700 | 1.63 | 149.0582[M + H-H2O]+; 121.0644[M + H-H2O-CO]+ | PRR |
53 | 22.20 | C18H19NO4 | N-E-feruloyl tyramine | 314.1377 | 3.14 | 177.0543; 145.0283; 121.0646 | LF |
54 | 22.26 | C27H30O11 | Neoicariin/wushanicariin/icariside I or their isomer (a) | 531.1852 | 1.68 | 369.1323[M + H-glu]+; 313.0701[M + H-glu-isobutenyl]+ | EH |
55 | 22.38 | C39H50O20 | Epimedin A (hexandraside F)R | 839.2944 | 2.89 | 677.2318[M + H-glu]+; 531.1852[M + H-glu-rha]+; 369.1326[M + H-2glu-rha]+; 313.0697[M + H-2glu-rha-isobutenyl]+ | EH |
56 | 22.42 | C28H34O14 | Poncirin/didymin | 595.2002 | 3.25 | 433.1456[M + H-glu]+; 287.0909[M + H-glu-rha]+; 171.0285; 153.0180 | CRP |
57 | 22.45 | C22H22O9 | Ononin | 415.1376 | 0.11 | 283.0845[M + H-glu]+; 219.0253; 183.0275; 132.0433; 89.0590 | AR |
58 | 22.51 | C16H12O5 | CalycosinR | 285.0748 | 3.34 | 171.0275; 161.0595 | AR |
59 | 22.51 | C28H32O14 | Robinia pseudoxanthin-7-O-rutinoside | 593.1850 | 2.50 | 447.1188[M + H-rha]+; 285.075[M + H-rha-glu]+ | PF |
60 | 22.98 | C38H48O19 | Epimedin BR | 809.2841 | 2.67 | 677.2428[M + H-xyl]+; 531.1852[M + H-xyl-rha]+; 369.1324[M + H-xyl-rha-glu]+; 313.0698[M + H-xyl-rha-glu-isobutenyl]+ | EH |
61 | 22.98 | C27H30O11 | Neoicariin/wushanicariin/icariside I or their isomer (b) | 531.1852 | 1.68 | 369.1326[M + H-glu]+; 313.0699[M + H-glu-isobutenyl]+ | EH |
62 | 23.13 | C33H53NO7 | Yibeinoside A or its isomer (b) | 576.3878 | 2.92 | 414.3355[M + H-glu]+ | FTB |
63 | 23.26 | C27H30O11 | Neoicariin/wushanicariin/icariside I or their isomer (c) | 531.1852 | 1.68 | 369.1328[M + H-glu]+; 313.0699[M + H-glu-isobutenyl]+ | EH |
64 | 23.28 | C39H50O19 | Epimedin C (baohuside VI)R | 823.2999 | 2.44 | 677.2422[M + H-rha]+; 531.1848[M + H-2rha]+; 369.1324[M + H-2rha-glu]+; 313.0698[M + H-3rha-glu]+ | EH |
65 | 23.34 | C27H41NO3 | Peimisine isomer (e) | 428.3171 | −2.76 | 410.3058[M + H-H2O]+ | FTB |
66 | 23.40 | C30H34O17 | Sudachiin B/C | 667.1860 | 1.32 | 361.0916; 346.0653; 315.0478 [24] | CRP |
67 | 23.52 | C27H45NO3 | Isopeimine A | 432.3473 | 0.05 | 414.3356[M + H-H2O]+ | FTB |
68 | 23.58 | C21H20O6 | Anhydroicaritin or its isomer (a) | 369.1328 | 1.26 | 323.0738; 313.0687[M + H-isobutenyl]+ | EH |
69 | 23.60 | C33H40O15 | IcariinR | 677.2423 | 2.51 | 531.1846[M + H-rha]+; 369.1322[M + H-rha-glu]+; 311.0697[M + H-rha-glu-isobutenyl]+ | EH |
70 | 23.60 | C27H30O11 | Neoicariin/wushanicariin/icariside I or their isomer (d) | 531.1852 | 1.68 | 369.1323[M + H-glu]+; 313.0698[M + H-glu-isobutenyl]+ | EH |
71 | 23.68 | C47H78O19 | Astragaloside V/VI/VII | 947.5190 | 2.12 | 437.3372; 419.3230 [26] | AR |
72 | 23.69 | C36H62O9 | 20(R)-Ginsenoside Rh1 | 639.4458 | 1.35 | 405.3482; 423.3584; 441.368 [27] | GRR |
73 | 23.72 | C22H22O10 | Calycosin-7-O-glu or its isomer (b) | 447.1287 | −0.28 | 285.0751[M + H-glu]+; 149.0223; 89.0594 | AR |
74 | 23.77 | C33H55NO7 | Hupeheninoside | 578.4039 | 2.13 | 416.3525[M + H-glu]+ | FTB |
75 | 23.85 | C15H12O5 | Naringenin isomer (b) | 273.0750 | 2.76 | 247.0638; 171.0307; 153.0204 [2] | CRP |
76 | 23.87 | C41H52O21 | Epimedin I | 881.3035 | −4.38 | 531.1829[M + H-glu-acetyl rha]+; 369.1328[M + H-glu-acetyl rha-glu]+; 313.0697[M + H-glu-acetyl rha-glu-isobutenyl]+ | EH |
77 | 23.91 | C27H32O11 | Icaritin-3-O-rha | 533.2007 | 1.95 | 387.1393[M + H-rha]+; 369.1314[M + H-rha-H2O]+; 313.0701[M + H-rha-H2O-isobutenyl]+ | EH |
78 | 23.99 | C27H43NO3 | Peiminine B isomer | 430.3306 | 2.26 | 412.3210[M + H-H2O]+ | FTB |
79 | 24.05 | C48H82O18 | Ginsenoside ReR | 947.5531 | 4.53 | 325.1117 | GRR |
80 | 24.07 | C54H92O23 | Ginsenoside Rb1R | 1109.6097 | 0.47 | 487.1687; 425.3734; 325.1105 | GRR |
81 | 24.09 | C40H50O20 | Sempervirenoside B | 851.2945 | 2.73 | 369.1315[M + H-glu-rha (OAc)-xyl]+; 313.0700[M + H-glu-rha (OAc)-xyl-isobutenyl]+ | EH |
82 | 24.21 | C33H40O18 | Melitidin | 725.2269 | 2.54 | 419.1328; 389.0858; 361.0910 [24] | CRP |
83 | 24.23 | C26H28O11 | Epimedoside C | 517.1690 | 2.79 | 355.1173[M + H-glu]+; 299.0547[M + H-glu-isobutenyl]+ | EH |
84 | 24.2 | C53H90O22 | Ginsenoside Rb2/ginsenoside Rc/ginsenoside Rb3 | 1079.6003 | −0.6 | 457.1532; 425.3733; 407.3638; 325.1110 [27] | GRR |
85 | 24.31 | C53H90O22 | Ginsenoside Rb2/ginsenoside Rc/ginsenoside Rb3 | 1079.5966 | 2.83 | 457.1523; 425.3726; 325.1110 | GRR |
86 | 24.35 | C10H14O | PerillaldehydeR | 151.1114 | 2.28 | 123.0438; 95.0489 | PF |
87 | 24.37 | C20H18O6 | Desmethylanhydroicaritin or its isomer (a) | 355.1197 | −5.89 | 299.0546[M + H-isobutenyl]+ | EH |
88 | 24.37 | C9H10O3 | Paeonol | 167.0698 | 2.83 | 149.0579; 121.0641 | GRR |
89 | 24.39 | C36H56O9 | Calenduloside E | 633.3981 | 2.55 | 439.3530 [27] | GRR |
90 | 24.39 | C48H76O19 | Ginsenoside Ro | 957.5087 | −3.50 | 439.3530; 414.3343 [27] | GRR |
91 | 24.41 | C27H43NO2 | Ebeiedinone/delavinone/zhebeirine (puqiedinone) (a) | 414.3354 | 3.04 | 396.3243[M + H-H2O]+ | FTB |
92 | 24.43 | C41H68O14 | Astragaloside IvR | 785.4669 | 1.64 | 587.3879; 455.3473; 437.3373; 419.3258 | AR |
93 | 24.47 | C43H54O22 | Epimedokoreanoside I | 923.3163 | 1.79 | 719.2438[M + H-glu (OAc)]+; 531.1782[M + H-glu (OAc)-rha (OAc)]+; 369.1328[M + H-glu (OAc)-rha (OAc)-glu]+; 313.0699[M + H-glu (OAc)-rha (OAc)-glu-isobutenyl]+ | EH |
94 | 24.5 | C30H32O12 | Benzoylpaeoniflorin/paeonivayin or their isomer (a) | 585.1964 | 0.43 | 123.0432 [25] | PR |
95 | 24.51 | C15H12O5 | NaringeninR | 273.0750 | 2.76 | 247.0639; 229.0517; 171.0307; 153.0183; 147.0442 | CRP |
96 | 24.51 | C15H24O | Spathulenol | 221.1896 | 1.78 | 203.1772[M + H-H2O]+ | EH |
97 | 24.59 | C15H10O5 | ApigeninR | 271.0593 | 2.96 | 245.0643[M + H-O]+; 229.0854; 177.0542; 121.0281; 107.0488 | PF |
98 | 24.61 | C35H42O16 | Epimedokoreanoside II/sagittatoside C | 719.2521 | 3.43 | 369.1332[M + H-glu-rha (OAc)]+; 313.0700[M + H-glu-rha (OAc)-isobutenyl]+ | EH |
99 | 24.63 | C31H36O14 | Ikarisoside F | 633.2161 | 2.66 | 355.1166[M + H-rha-xyl]+; 299.0546[M + H-rha-xyl-isobutenyl]+ | EH |
100 | 24.69 | C27H43NO2 | Ebeiedinone/delavinone/zhebeirine (puqiedinone) (b) | 414.3354 | 3.04 | 396.3246[M + H-H2O]+ | FTB |
101 | 24.69 | C33H53NO7 | Yibeinoside A or its isomer (c) | 576.3872 | 3.96 | 558.3722[M + H-H2O]+; 396.3239[M + H-H2O-glu]+ | FTB |
102 | 24.73 | C15H24O | Caryophyllene oxide or its isomer (a) | 221.1896 | 1.78 | 203.1786[M + H-H2O]+CFM-ID | PF/AJH |
103 | 24.81 | C36H62O9 | 20(S)-ginsenoside Rh1 | 639.4478 | 2.66 | 441.3716; 423.3512; 405.3509 | GRR |
104 | 24.81 | C16H12O6 | Chrysoeriol | 301.0698 | 2.88 | 286.0468[M + H-CH3]+; 258.0519[M + H-CH3-CO2]+; 177.0544; 153.0182 [28] | PF, AR |
105 | 24.83 | C15 H22 O | Chamigrenal isomer or its isomer (a) | 219.1737 | 2.94 | 203.1425; 121.1009CFM-ID | SCF |
106 | 24.93 | C45H56O23 | Caohuoside A (epimedin L)/caohuoside B/epimedin K (korepimedoside B) | 965.3265 | 2.09 | 369.1313[M + H-glu (2OAc)-rha (OAc)-glu]+; 313.0694[M + H-glu (2OAc)-rha (OAc)-glu-isobutenyl]+ | EH |
107 | 24.93 | C18H16O8 | Trihydroxy-trimethoxyflavone | 361.0907 | 3.04 | 331.0441[M + H-2CH3]+ | CRP |
108 | 24.97 | C43H70O15 | Astragaloside II/isoastragaloside II | 827.4761 | 3.20 | 629.3947; 175.0599[Xyl (OAc)+H]+ 157.0494[Xyl (OAc)+H-H2O]+ [26] | AR |
109 | 24.99 | C18H16O9 | Tetrahydroxy-trimethoxyflavone | 377.0857 | 2.68 | 362.0611[M + H-CH3]+; 347.0385[M + H-2CH3]+; 319.0427[M + H-2CH3-CO]+ | CRP |
110 | 25.01 | C26H28O10 | Baohuoside II | 501.1738 | 3.45 | 355.1169[M + H-rha]+; 299.0544[M + H-rha-isobutenyl]+; 121.0274 | EH |
111 | 25.01 | C20H18O6 | Desmethylanhydroicaritin or its isomer (b) | 355.1197 | −5.89 | 299.0546[M + H-isobutenyl]+ | EH |
112 | 25.13 | C17H14O8 | Tetrahydroxy-dimethoxyflavone (b) | 347.0753 | 2.44 | 287.0533[M + H-2OCH3]+ | CRP |
113 | 25.15 | C21H20O6 | Anhydroicaritin or its isomer (b) | 369.1328 | 1.26 | 313.0700[M + H-isobutenyl]+ | EH |
114 | 25.15 | C33H40O15 | Anhydroicaritin-3-O-Γ-L-rhamnosyl-7-O-Δ-D-Glucopyranoside/sagittatoside A | 677.2426 | 2.07 | 369.1324[M + H-glu-rha]+; 313.0700[M + H-glu-rha-isobutenyl]+; 225.1012 | EH |
115 | 25.21 | C30H32O12 | Benzoylpaeoniflorin/paeonivayin or their isomer (b) | 585.1951 | 2.66 | 123.0437 [25] | PR |
116 | 25.23 | C48H78O18 | Soyasaponin I | 943.5243 | 1.90 | 441.3683; 423.3577CFM-ID | AR |
117 | 25.34 | C16H12O4 | FormononetinR | 269.0806 | 0.88 | 254.0566; 237.0544; 213.0908; | AR |
118 | 25.34 | C19H20O7 | Monohydroxy-tetramethoxyflavanone | 361.1273 | 2.44 | 211.0574 [24] | CRP |
119 | 25.34 | C20H22O7 | Pentamethoxyflavanone (a) | 375.1434 | 1.15 | 211.0588 [24] | CRP |
120 | 25.38 | C21H20O6 | Anhydroicaritin or its isomer (c) | 369.1328 | 1.26 | 313.7[M + H-rha-isobutenyl]+ | EH |
121 | 25.38 | C32H38O14 | Sagittatoside B | 647.2322 | 1.91 | 515.1830[M + H-xyl]+; 369.1330[M + H-xyl-rha]+; 313.0702[M + H-xyl-rha-isobutenyl]+ | EH |
122 | 25.42 | C33H40O14 | 2″-O-rhamnosylicariside II/anhydroicaritin 3-O-2″-rha-rha | 661.2476 | 2.25 | 515.1898[M + H-rha]+; 369.1328[M + H-2rha]+; 313.0699[M + H-2rha-isobutenyl]+ | EH |
123 | 25.54 | C27H41NO3 | Peimisine isomer (f) | 428.3171 | −2.76 | 410.3037[M + H-H2O]+ | FTB |
124 | 25.56 | C15H16O4 | Meranzin/isomeramazin (b) | 261.1117 | 1.67 | 189.0536; 131.0483MB | CRP |
125 | 25.59 | C42H72O13 | Ginsenoside Rg2R | 785.5023 | 2.89 | 441.3702; 423.3601 [27] | GRR |
126 | 25.66 | C20H20O7 | IsosinensetinR | 373.1275 | 1.83 | 357.0966; 343.0877; 315.0858 | CRP |
127 | 25.72 | C27H30O11 | Neoicariin/wushanicariin/icariside I or their isomer (e) | 531.1852 | 1.68 | 369.1325[M + H-glu]+; 313.0700[M + H-isobutenyl]+ | EH |
128 | 25.78 | C45H72O16 | Astragaloside I/isoastragaloside I | 869.4894 | −0.10 | 157.0482[Xyl (OAc) + H-H2O]+ [26] | AR |
129 | 25.86 | C21H22O8 | Hexamethoxyflavone (a) | 403.1381 | 1.6 | 388.1140; 373.0914; 358.0642; 327.0588 [24] | CRP |
130 | 25.92 | C26H32O8 | Deacetylnomilin | 473.2163 | 1.47 | 161.0598 [24] | CRP |
131 | 25.94 | C36H60O8 | Ginsenoside Rk3/Rh4 | 621.4347 | 2.25 | 405.3362 [28] | GRR |
132 | 26.02 | C21H20O6 | Anhydroicaritin or its isomer (d) | 369.1328 | 1.26 | 313.0699[M + H-isobutenyl]+ | EH |
133 | 26.02 | C27H30O10 | Icariside II (baohuside I) | 515.1907 | 0.92 | 369.1328[M + H-rha]+; 313.0701[M + H-rha-isobutenyl]+ | EH |
134 | 26.16 | C20H20O7 | Sinensetin | 373.1279 | 0.75 | 357.0968; 343.0805; 329.1013; 297.0734 [24] | CRP |
135 | 26.24 | C11H16O | Jasmonane | 165.1273 | 0.56 | 123.1172MoNA | PF |
136 | 26.26 | C22H26O6 | Gomisin L1 or its isomer (a) | 387.1800 | 0.56 | 287.0549[M + H-C5H10-2CH3]+ | SCF |
137 | 26.26 | C11H14O2 | Methyl eugenolR | 179.1067 | −0.25 | 151.0752; 116.9718 | PF |
138 | 26.28 | C19H18O6 | Tetramethyl-O-scutellarein/tetramethyl-O-isoscutellarein/tetramethoxyflavone (a) | 343.1173 | 0.92 | 313.0701[M + H-2CH3]+; 285.0751[M + H-2CH3-CO]+ | CRP |
139 | 26.34 | C20H22O7 | Pentamethoxyflavanone (b) | 375.1436 | 0.61 | 211.0596; 150.0304 [24] | CRP |
140 | 26.42 | C18H39NO3 | D-ribo-phytosphingosineR | 318.2998 | 1.48 | 300.2895[M + H-H2O]+; 282.2784[M + H-2H2O]+; | PF |
141 | 26.48 | C24H32O7 | Schisandrol AR | 433.2128 | −0.05 | 415.2106[M + H-H2O]+; 400.1871[M + H-H2O-CH3]+; 384.1922; 369.1688; 338.1504 | SCF |
142 | 26.57 | C19H18O8 | Rosmarinic acid methylester | 375.1076 | -0.42 | 135.0435 | PF |
143 | 26.61 | C21H22O8 | NobiletinR | 403.1384 | 0.86 | 388.1145[M + H-CH3]+; 373.0912[M + H-2CH3]+; 358.0672[M + H-3CH3]+; 327.0857; 301.0701 | CRP |
144 | 26.63 | C18H32O3 | 13-Hydroxy-9,11-octadecadienoic acid or its isomer (a) | 297.2416 | 2.77 | 279.2318[M + H-H2O]+; 261.2202[M + H-2H2O]+ | AR |
145 | 26.63 | C18H30O2 | a-Linolenic acid or its isomer (a) | 279.2308 | 3.80 | 261.2190[M + H-H2O]+; 149.0232; 121.0282MoNA | PF/EH |
146 | 26.83 | C19H18O6 | Tetramethyl-O-scutellarein/tetramethyl-O-isoscutellarein/tetramethoxyflavone (b) | 343.1174 | 0.63 | 313.0701[M + H-2CH3]+; 285.0750[M + H-2CH3-CO]+ | CRP |
147 | 26.97 | C22H24O9 | 3,5,6,7,8,3′,4′-heptamethoxyflavone | 433.1488 | 1.18 | 418.1244[M + H-CH3]+; 403.1016[M + H-2CH3]+; 388.0700[M + H-3CH3]+; 373.0541[M + H-4CH3]+ [24] | CRP |
148 | 27.07 | C18H32O3 | 13-hydroxy-9,11-octadecadienoic acid or its isomer (b) | 297.2416 | 2.77 | 279.2313[M + H-H2O]+; 261.2217[M + H-2H2O]+ | AR |
149 | 27.17 | C42H70O12 | Ginsenoside Rg5/Rk1 | 767.4932 | 1.05 | 605.4375[M + H-glu]+; 439.3837; 425.3744; 407.3635 | GRR |
150 | 27.29 | C23H28O7 | Schisandrol B/epigomisin O | 417.1900 | 1.87 | 399.1796[M + H-H2O]+; 368.1609; 299.0598; 119.0854 | SCF |
151 | 27.29 | C20H20O7 | TangeretinR | 373.1277 | 1.29 | 343.0807[M + H-2CH3]+; 297.0753; 229.0328; 135.0437 | CRP |
152 | 27.39 | C28H34O9 | Schisantherin C (angeloylgomisin P) or its isomer (a) | 515.2258 | 3.42 | 385.1667 [M + H-C4H6COOH-CH2O]+; 355.1537[M + H-C4H6COOH-2CH2O]+; 339.1198; 316.0930; 301.0690 | SCF |
153 | 27.75 | C21H22O8 | Hexamethoxyflavone (b) | 403.1380 | 1.85 | 388.1145[M + H-CH3]+; 373.0913[M + H-2CH3]+; 355.0803[M + H-CH3-H2O]+; 327.0856[M + H-CH3-CO]+ [24] | CRP |
154 | 27.89 | C28H36O8 | Angeloylgomisin H or its isomer (a) | 501.2473 | 1.99 | 483.2372[M + H-H2O]+; 437.1929; 401.1953[M + H-C4H6COOH]+ | SCF |
155 | 27.93 | C23H28O6 | Schisandrin B (γ-schisandrin) isomer (a) | 401.1945 | 3.41 | 386.1718[M + H-CH3]+; 370.1762; 355.1531; 345.1320 | SCF |
156 | 27.95 | C20H22O7 | Pentamethoxyflavanone (c) | 375.1432 | 1.68 | 357.0634; 211.0595 [24] | CRP |
157 | 28.01 | C28H34O8 | Benzoyl isogomisin O or its isomer | 499.2328 | −0.31 | 483.2370[M + H-O]+; 451.2118[M + H-O-CH3OH]+ | SCF |
158 | 28.09 | C15 H22 O | Chamigrenal isomer or its isomer (b) | 219.1737 | 2.94 | 203.1429CFM-ID | SCF |
159 | 28.12 | C23H28O6 | Schisandrin B (γ-schisandrin) isomer (b) | 401.1945 | 3.41 | 386.1718[M + H-CH3]+; 370.1764; 355.1530; 345.1324 | SCF |
160 | 28.14 | C28H36O8 | Angeloylgomisin H or its isomer (b) | 501.2469 | 2.79 | 483.2372[M + H-H2O]+; 437.1929; 401.1955[M + H-C4H6COOH]+; 370.1768 | SCF |
161 | 28.26 | C22H26O6 | Gomisin L1 or its isomer (b) | 387.1800 | 0.56 | 287.0548[M + H-C5H10-2CH3]+ | SCF |
162 | 28.36 | C18H30O2 | a-Linolenic acid or its isomer (b) | 279.2308 | 3.80 | 263.2362; 149.0232; 121.0282; 95.0854MoNA | PF/EH |
163 | 28.46 | C21H22O9 | Natsudaidai | 419.1326 | 2.53 | 389.0862[M + H-2CH3]+; 361.0892[M + H2CH3CO]+; 299.0611; 181.0855 | CRP |
164 | 28.46 | C22H24O6 | Schisandrin C isomer | 385.1631 | 3.81 | 355.1545[M + H-CH2O]+; 337.1415[M + H-CH2O-H2O]+; 316.0928 | SCF |
165 | 28.52 | C30H34O8 | Benzoyl gomisin H | 523.2314 | 2.38 | 505.2202[M + H-H2O]+; 401.1912; 370.1731 | SCF |
166 | 28.52 | C25H26O6 | Epimedokoreanin B | 423.1790 | 2.88 | 311.0522[M + H-2isobutenyl]+ | EH |
167 | 28.52 | C23H30O6 | Gomisin K1 | 403.2105 | 2.52 | 388.1869[M + H-CH3]+; 371.1848; 340.1656; 333.1236; 302.1237 | SCF |
168 | 28.56 | C30H48O4 | Corosolic acidR | 473.3614 | 2.41 | 409.3441; 205.1585; 189.1642; 177.1634; 95.0853 | PF |
169 | 28.95 | C28H34O9 | Schisantherin BR | 515.2266 | 1.87 | 415.1732[M + H-C4H6COOH]+ | SCF |
170 | 29.00 | C22H26O6 | Gomisin L1 or its isomer (c) | 387.1800 | 0.56 | 355.1521[M + H-CH3OH]+; 317.1023[M + H-C5H10]+; 287.0540[M + H-C5H10-2CH3]+ | SCF |
171 | 29.00 | C23H26O7 | Neoisostegane | 415.1740 | 2.73 | 397.1630[M + H-H2O]+; 371.1483[M + H-CO2]+; 356.1243; 340.1299 | SCF |
172 | 29.00 | C23H30O6 | Schisanhenol | 403.2105 | 2.52 | 388.1877[M + H-CH3]+; 371.1856[M + H-CH3-OH]+; 356.1614; 340.1665; 325.1429; 305.1322 | SCF |
173 | 29.04 | C30H32O9 | Schisantherin AR | 537.2109 | 1.88 | 415.1724; 268.9779; 91.0565 | SCF |
174 | 29.06 | C15 H22 O | Chamigrenal isomer or its isomer (c) | 219.1737 | 2.94 | 203.1438CFM-ID | SCF |
175 | 29.14 | C28H34O9 | Schisantherin C (angeloylgomisin P) or its isomer (b) | 515.2258 | 3.42 | 385.1630 [M + H-C4H6COOH-CH2O]+; 355.1498[M + H-C4-H6COOH-2CH2O]+; 339.1175; 316.0931; 301.0695 | SCF |
176 | 29.30 | C22H26O6 | Gomisin L1 or its isomer (d) | 387.1800 | 0.56 | 355.0541[M + H-CH3OH]+; 317.1023[M + H-C5H10]+; 287.0536[M + H-C5H10-2CH3]+ | SCF |
177 | 29.50 | C22H22O7 | Baohuosu | 399.1425 | 3.34 | 355.1163[M + H-C3H6]+; 325.1052 | EH |
178 | 29.59 | C18H32O3 | 13-Hydroxy-9,11-octadecadienoic acid or its isomer (c) | 297.2416 | 2.77 | 279.2316[M + H-H2O]+; 261.2198[M + H-H2O]+ | AR |
179 | 29.63 | C28H34O9 | Schisantherin C (angeloylgomisin P) or its isomer (c) | 515.2258 | 3.42 | 385.1630[M + H-C4H6COOH-CH2O]+; 355.1525[M + H-C4H6COOH-2CH2O]+; 339.1222; 316.0939; 301.0708 | SCF |
180 | 29.71 | C22H26O6 | Gomisin L1 or its isomer (e) | 387.1800 | 0.56 | 355.1543[M + H-CH3OH]+; 317.1017[M + H-C5H10]+; 287.0540[M + H-C5H10-2CH3]+ | SCF |
181 | 29.71 | C19H20O6 | Tetramethoxyflavanone | 345.1321 | 3.38 | 330.1086[M + H-CH3]+; 315.0858[M + H-2CH3]+; 297.0932[M + H-2CH3-H2O]+; 287.0883[M + H-2CH3-CO]+; 247.0438 | CRP |
182 | 29.96 | C15 H22 O | Chamigrenal isomer or its isomer (d) | 219.1737 | 2.94 | 203.1438; 149.0594; 135.0803; 121.1005CFM-ID | SCF |
183 | 30.27 | C24H32O6 | Schisandrin AR | 417.2258 | 3.28 | 402.2029[M + H-CH3]+; 386.2079[M + H-CH3-O]+; 371.1832[M + H-2CH3-O]+; 347.1481; 316.1296; 301.1062 | SCF |
184 | 30.92 | C18H30O2 | a-linolenic acid or its isomer (c) | 279.2308 | 3.80 | 263.2366; 149.0231; 121.0282; 95.0853MoNA | PF/EH |
185 | 31.1 | C23H28O6 | Schisandrin BR | 401.1945 | 3.41 | 386.1717; 370.1769; 355.1532; 331.1166; 300.0985; 285.0753; 270.0878 | SCF |
186 | 31.16 | C15H24 | Trans-α-acacia | 205.1943 | 3.81 | 107.0849; 93.0694; 69.0696MoNA | PF |
187 | 31.18 | C15H24O | Caryophyllene oxide or its isomer (b) | 221.1894 | 2.69 | 203.1775[M + H-H2O]+CFM-ID | PF/AJH |
188 | 31.22 | C12H16O7 | ArbutinR | 273.0958 | 3.97 | 157.0121; 139.0016; 129.0180 | SCF |
189 | 31.75 | C22H24O6 | Schisandrin CR | 385.1631 | 3.81 | 355.1518; 315.0834; 285.0753; 257.0812; 228.0695 | SCF |
|